← back to search

Roberto Labianca

University of Bergamo · IT
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes, Colorectal Cancer Surgical Treatments, and Genetic factors in colorectal cancer.
h-index
82
citations
39,291
works
549
NIH funding
primary concept
Medicine
email

Recent publications

Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology 2020cited by 1,293position: middledoi
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
New England Journal of Medicine 2018cited by 1,118position: middledoi
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease
The Lancet Oncology 2018cited by 70position: middledoi
Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group
European Journal of Cancer 2018cited by 34position: middledoi
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Annals of Oncology 2016cited by 3,428position: middledoi
Position Paper of the Italian Association of Medical Oncology on Early Palliative Care in Oncology Practice (Simultaneous Care)
Tumori Journal 2016cited by 17position: middledoi
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study
Modern Pathology 2015cited by 316position: middledoi
Addressing the challenges of pancreatic cancer: Future directions for improving outcomes
Pancreatology 2014cited by 506position: middledoi
Prognostic impact of deficient mismatch repair (dMMR) in 7,803 stage II/III colon cancer (CC) patients (pts): A pooled individual pt data analysis of 17 adjuvant trials in the ACCENT database.
Journal of Clinical Oncology 2014cited by 76position: middledoi
Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)
European Journal of Cancer 2014cited by 69position: middledoi
Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II study
Digestive and Liver Disease 2013cited by 51position: middledoi
A prospective study on survival in cancer patients with and without venous thromboembolism
Internal and Emergency Medicine 2013cited by 35position: lastdoi
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
Annals of Oncology 2012cited by 1,529position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Daniel J. Sargent · National Institute of Agricultural Botany2 papers (2014–2018)Julien Taı̈eb · Assistance Publique – Hôpitaux de Paris2 papers (2018–2020)Stefano Cascinu · Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele2 papers (2013–2014)Qian Shi · Tongji University2 papers (2014–2018)Timothy Iveson · University Hospital Southampton NHS Foundation Trust2 papers (2018–2020)Takayuki Yoshino · Kindai University2 papers (2018–2020)Thierry André · Inserm2 papers (2014–2018)Daniel Hochhauser · University College London1 papers (2020–2020)Manuel Hidalgo · Artistic Realization Technologies1 papers (2014–2014)Daris Ferrari · IRCCS Humanitas Research Hospital1 papers (2013–2013)Pierre Laurent‐Puig · Délégation Paris 51 papers (2020–2020)Paolo Bidoli · Azienda Ospedaliera San Gerardo1 papers (2013–2013)Giovanni Di Minno · University of Vermont1 papers (2013–2013)Stephen N. Thibodeau · Mayo Clinic in Arizona1 papers (2014–2014)Alberto F. Sobrero · University Hospital Heidelberg1 papers (2013–2013)Armando Santoro · Humanitas University1 papers (2013–2013)Giancarlo Agnelli · University of Perugia1 papers (2013–2013)Toshiaki Watanabe · ShinEtsu Chemical (Japan)1 papers (2018–2018) · 1 papers (2013–2013)Arnaud Roth · University of Lausanne1 papers (2014–2014)